Interesting problem. Unproven company.
Executive verdict
The deck proves customer urgency, but not that RelayOps is positioned to own the problem. Investors will likely see a useful AI feature without enough evidence of repeatable demand, economic durability, or a defensible wedge. The answer is not a longer deck. It is a more specific one.
What they may think but won’t say
“I cannot tell whether this is early commercial proof or optimistic packaging around a handful of pilots.”
Risks that can kill the meeting
Finding 01
Traction overstates commercial proof
“18 design partners” — slide 6
The deck combines free pilots and paying customers without separating conversion, retention, or revenue quality.
Decision consequence
An investor cannot distinguish genuine pull from founder-subsidized experimentation.
Likely challenge
“How many customers pay today, how much, for how long—and how many pilots converted or churned?”
Repair
Split the cohort into paid, pilot, churned, and converted accounts, then show revenue and retention by customer.
Confidence · HIGH
Score breakdown
The problem and workflow are easy to understand.
The pain is credible, but buying urgency is not quantified.
Useful product, weak separation from adjacent tooling.
Early signals exist, but commercial proof is blurred.
No auditable unit economics or repeatable sales motion.
No compounding advantage is evidenced.
Questions to survive
- 01How many customers pay today, and what did each pay?
- 02What percentage of pilots converted, expanded, or churned?
- 03Why is this a company rather than an incumbent feature?
- 04What proprietary advantage compounds with usage?
- 05How was the 62% MTTR improvement measured?
- 06Which acquisition channel produced the paying cohort?
- 07What is the current sales cycle and who owns the budget?
- 08What proof will this round buy before the next financing?
Revision order
- 1
Rebuild the traction slide around paid cohorts, conversion, retention, and revenue quality.
Slide 6
- 2
Replace category language with a defensibility argument supported by workflow or data evidence.
Slides 4, 10
- 3
Make the ROI claim auditable and tie the raise to measurable de-risking milestones.
Slides 5, 12